NASDAQ · KYTX
Kyverna Therapeutics, Inc.
Smart money pulse
What insiders and funds are doing
Mixed Insiders: as of Nov 12 Funds: as of Jun 30, 2026
- account_balance69 funds bought, 48 sold in the quarter ended Jun 30, 2026. 34 were new holders.
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
−100 means everyone selling, +100 everyone buying. This is data, not advice.
How the Pulse works
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.
Who owns it
121 funds report owning KYTX, up from 109
New34
Added35
Held26
Trimmed26
Sold out22
Last quarter
Who bought and who sold
BlackRock, Inc.
+257%
State Street Corp
+610%
Change in shares held, biggest holdings first. Bars stop at ±100%.
Insider trades · last 12 months
Real buys and sales
No insider filings loaded for the last 12 months.
Top holders
Biggest funds in KYTX
| Fund | Value | Change |
|---|---|---|
| GordonMD Global Investments LP | $37.8M | Same |
| Gilead Sciences, Inc. | $36.8M | Same |
| BlackRock, Inc. | $27.9M | +257% |
| Bain Capital Life Sciences Investors, LLC | $25.7M | −7% |
| AIGH Capital Management LLC | $24.9M | +40% |